BoneSupport AB:企業の製品パイプライン分析

◆英語タイトル:BoneSupport AB - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME3874PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥210,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥315,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; disease or related to surgical procedures. The company develops its bone graft substitutes using its patented technology platform CERAMENT. Its major products include bone void filler and vancomycin-eluting synthetic bone substitute. BoneSupport also carries out various pre-clinical product candidates intended to promote bone growth. The company markets its products through a network of distributors in Europe and North America. BoneSupport is headquartered in Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BoneSupport AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
BoneSupport AB Company Overview
BoneSupport AB Company Snapshot
BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
BoneSupport AB – Pipeline Analysis Overview
Business Description
BoneSupport AB – Key Facts
BoneSupport AB – Major Products and Services
BoneSupport AB Pipeline Products by Development Stage
BoneSupport AB Ongoing Clinical Trials by Trial Status
BoneSupport AB Pipeline Products Overview
CERAMENT + Bisphosphonate
CERAMENT + Bisphosphonate Product Overview
CERAMENT + Bisphosphonates And BMP
CERAMENT + Bisphosphonates And BMP Product Overview
Cerament + BMP
Cerament + BMP Product Overview
Cerament + BMP 2
Cerament + BMP 2 Product Overview
CERAMENT + BMP And Stem Cells
CERAMENT + BMP And Stem Cells Product Overview
Cerament|G
Cerament|G Product Overview
Cerament|G Clinical Trial
Gelatin/CERAMENT
Gelatin/CERAMENT Product Overview
BoneSupport AB – Key Competitors
BoneSupport AB – Key Employees
BoneSupport AB – Key Employee Biographies
BoneSupport AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
BoneSupport AB, Recent Developments
Nov 19, 2020: Simon Cartmell leaves Bonesupport’s board of directors
Jun 08, 2020: BONESUPPORT starts its own sales organization in the Netherlands
Feb 12, 2020: Bonesupport Holding: Change in the management team
Dec 18, 2019: BONESUPPORT appoints Kristina Ingvar to executive vice president quality management & regulatory affairs
Dec 09, 2019: BoneSupport CERTiFy study on Cerament Bone Void Filler now published in the journal of bone and joint surgery
Nov 12, 2019: BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW
Sep 18, 2019: BONESUPPORT HOLDING presents health economic evidence
Aug 28, 2019: BONESUPPORT announces partnership with Academy Medical
Aug 21, 2019: BONESUPPORT HOLDING announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
Jul 19, 2019: BONESUPPORT: Item affecting comparability in Q2 2019
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
BoneSupport AB Pipeline Products by Equipment Type
BoneSupport AB Pipeline Products by Indication
BoneSupport AB Ongoing Clinical Trials by Trial Status
BoneSupport AB, Key Facts
BoneSupport AB, Major Products and Services
BoneSupport AB Number of Pipeline Products by Development Stage
BoneSupport AB Pipeline Products Summary by Development Stage
BoneSupport AB Ongoing Clinical Trials by Trial Status
BoneSupport AB Ongoing Clinical Trials Summary
CERAMENT + Bisphosphonate - Product Status
CERAMENT + Bisphosphonate - Product Description
CERAMENT + Bisphosphonates And BMP - Product Status
CERAMENT + Bisphosphonates And BMP - Product Description
Cerament + BMP - Product Status
Cerament + BMP - Product Description
Cerament + BMP 2 - Product Status
Cerament + BMP 2 - Product Description
CERAMENT + BMP And Stem Cells - Product Status
CERAMENT + BMP And Stem Cells - Product Description
Cerament|G - Product Status
Cerament|G - Product Description
Cerament|G - A Prospective, Randomized Multicenter Controlled Trial of CERAMENT|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures
Cerament|G - CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy)
Cerament|G - Two-stage Treatment of Large Bone Defects with Cerament G and Cerament V plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy after Bone Resection in Patients with Septic Pseudarthrosis
Gelatin/CERAMENT - Product Status
Gelatin/CERAMENT - Product Description
BoneSupport AB, Key Employees
BoneSupport AB, Key Employee Biographies
BoneSupport AB, Subsidiaries
Glossary

★海外企業調査レポート[BoneSupport AB:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Satair A/S:企業の戦略・SWOT・財務情報
    Satair A/S - Strategy, SWOT and Corporate Finance Report Summary Satair A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Symbiomix Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Symbiomix Therapeutics LLC (Symbiomix) is a drug development company that offers development and commercialization of novel medicines. The company offers SYM-1219, for the treatment of several serious infections in women including bacterial vaginosis. Its SYM-1219 contains secnidazole, nitro …
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Health Net, LLC.:企業の戦略・SWOT・財務分析
    Health Net, LLC. - Strategy, SWOT and Corporate Finance Report Summary Health Net, LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Daily Mail and General Trust plc:企業のM&A・事業提携・投資動向
    Daily Mail and General Trust plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daily Mail and General Trust plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • enGene Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary enGene Inc (enGene) is a biotechnology company that focuses on transforming medicine by administering gene therapy as an oral drug. The company develops a mucosal immunotherapy platform for treating inflammatory bowel disease and diabetes. It also developed a non-viral gene-therapy platform …
  • Aspen Technology, Inc. (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology, Inc. (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alexander Forbes Group Holdings Ltd (AFH):企業の財務・戦略的SWOT分析
    Alexander Forbes Group Holdings Ltd (AFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Mount Tam Biotechnologies Inc (MNTM)-製薬・医療分野:企業M&A・提携分析
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamyci …
  • FortisBC Inc:企業の戦略的SWOT分析
    FortisBC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Electra Private Equity PLC (ELTA):企業の財務・戦略的SWOT分析
    Electra Private Equity PLC (ELTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • American Express Company:企業のM&A・事業提携・投資動向
    American Express Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American Express Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Orphazyme AS (ORPHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Orphazyme A/S (Orphazyme) formerly Orphazyme ApS, is a biopharmaceutical company that develops heat shock protein based therapies for the treatment of orphan protein-misfolding diseases. Its lead product drug candidate arimoclomol is under clinical development for treating neuromuscular dise …
  • Decmil Group Ltd (DCG):企業の財務・戦略的SWOT分析
    Summary Decmil Group Ltd (Decmil), is a provider of construction, engineering and accommodation and project management services. The company provides services such as design, accommodation services, civil engineering, construction, and maintenance services, among others. Decmil provides government i …
  • Barclays Bank of Kenya Ltd:企業の戦略・SWOT・財務分析
    Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Evogene Ltd (EVGN):企業の財務・戦略的SWOT分析
    Summary Evogene Ltd (Evogene), a subsidiary of Compugen Ltd, is a biotechnology company that offers plant genomic services. The company offers solutions for crop production improvement through breeding. It develops biotechnology and advanced breeding improved traits for crops that feed the world, in …
  • Nestle Health Science SA-医療機器分野:企業M&A・提携分析
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cabela’S Inc
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆